Top-News
Sonstige private Dienstleistungen Kanada

AI/ML Innovations Inc News

Aktie
WKN:  A2QMBE ISIN:  CA00143Y1034 US-Symbol:  AIMLF
0,0272 €
-0,0154 €
-36,15%
08.05.24 11:24:22
Handeln Depot/Watchlist
Aktienanzahl *
75,59 Mio.
Marktkapitalisierung *
3,01 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 02.04.2024

AI/ML Innovations Inc News

06.03.24 - IRW-Press
AI/ML Innovations Inc.-Tochter Health Gauge präsentiert eine revolutionäre, nicht-invasive Lösung zur Blutdruckmessung: „Follow Your Heart“
Wichtigste Eckdaten: - Wegweisende Präzision: Follow Your Heart basiert auf der von Health Gauge entwickelten revolutionären EdgeAI-​basierten AI PrecisionPulse Neural Network-...
11.04.23 - IRW-Press
AI/ML Innovations präsentiert „Health Coach“ – eine personalisierte, KI-gesteuerte Gesundheitsberatung
- Die Funktionalität von Health Coach ist vergleichbar mit jener von ChatGPT; sie ist jedoch darauf ausgelegt, die Gesundheit des Nutzers zu überwachen und zu managen. - Health ...
13.09.22 - ACCESSWIRE
AI/ML Innovations Inc. Provides Status Update
TORONTO, ON / ACCESSWIRE / September 13, 2022 / AI/ML Innovations Inc. ( "AI/ML" or the "Company" ) (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that further to its news ...
30.08.22 - ACCESSWIRE
AI/ML Innovations Inc. Granted Management Cease Trade Order
TORONTO, ON / ACCESSWIRE / August 30, 2022 / AI/ML Innovations Inc. (the " Company ") (CSE:AIML; OTCQB:AIMLF; FWB:42FB), a company committed to acquiring and ...
19.08.22 - ACCESSWIRE
AI/ML Innovations Inc. Announces Late Filing of Annual Financial Disclosure
TORONTO, ON / ACCESSWIRE / August 19, 2022 / AI/ML Innovations Inc. (the " Company ") (CSE:AIML; OTCQB: AIMLF; FWB:42FB), a company committed to acquiring and ...
02.08.22 - ACCESSWIRE
AI/ML Innovations’ Tech2Heal Announces Second Pilot Study of its Proprietary Healthcare Management Platform – Alakin
- Alakin to be utilized in a Parkinson study set to commence in Paris, France -
28.07.22 - ACCESSWIRE
AI/ML Innovations Inc. Announces Annual General Meeting Results
- All Resolutions Approved -
19.07.22 - ACCESSWIRE
AI/ML Innovations’ Tech2Heal Readies Release of Alakin - its Proprietary Healthcare Management Platform
- pre-​commercial pilot study set to commence in 30,000-patient primary care facility in Paris -
07.07.22 - ACCESSWIRE
AI/ML Innovations' Tech2Heal Launching Clinical Study for its Qookka Mental Health Digital Therapy
TORONTO, ON / ACCESSWIRE / July 7, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial ...
22.06.22 - ACCESSWIRE
AI/ML Innovations' Tech2Heal Starts Medical Device ISO 13485 Certification Process
TORONTO, ON / ACCESSWIRE / June 22, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial ...
09.06.22 - ACCESSWIRE
AI/ML Innovations' Tech2Heal Chosen as a Finalist in the i-Nov Innovation Contest
TORONTO, ON / ACCESSWIRE/ June 9, 2022 / AI/ML Innovations Inc. (CSE:AIML); (OTCQB:AIMLF); (FWB:42FB), a company committed to acquiring and advancing Artificial ...
04.05.22 - ACCESSWIRE
AI/ML Innovations Engages Octagon Media/Wall Street Reporter for Market Awareness and Announces Stock Option Grant
TORONTO, ON / ACCESSWIRE / May 4, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial ...
28.03.22 - ACCESSWIRE
AI/ML Innovations' Health Gauge Licenses its Patented Technology to MedWatch Technologies, Inc.
- MedWatch™ to address needs in the $327 billion-​dollar US diabetes market -
28.03.22 - IRW-Press
AI/ML Innovations-Tochter Health Gauge vergibt Lizenz für ihre patentierte Technologie an MedWatch Technologies, Inc.
- Zielmarkt von MedWatch ist der 327 Milliarden US-Dollar schwere Diabetesmarkt - Die Lizenz beinhaltet eine jährliche Lizenzgebühr in Höhe von 120.000 US-Dollar, eine ...
28.03.22 - ACCESSWIRE
AI/ML Innovations' Health Gauge Licenses its Patented Technology to MedWatch Technologies, Inc.
- MedWatch™ to address needs in the $327 billion-​dollar US diabetes market -
24.03.22 - ACCESSWIRE
AI/ML Innovations Inc. Completes Financing for Total Gross Proceeds of $600,000.00
TORONTO, ON / ACCESSWIRE / March 24, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial ...
07.02.22 - ACCESSWIRE
AI/ML Innovations' Tech2Heal Selected for Prestigious Health Tech Campus
TORONTO, ON / ACCESSWIRE / February 7, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial ...
01.02.22 - ACCESSWIRE
AI/ML Innovations' Health Gauge Granted US Patent
TORONTO, ON / ACCESSWIRE / February 1, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial ...
27.01.22 - ACCESSWIRE
AI/ML Innovations' Tech2Heal Chosen for Mental Health Innovation Accelerator Program
TORONTO, ON / ACCESSWIRE / January 27, 2022 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial ...
04.11.21 - ACCESSWIRE
AI/ML Innovations' Health Gauge Licenses Its Technology for a B2B COVID Rapid Testing Solution
Highlights:

Newssuche

Videos

09:05 Uhr -2,20%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »